LEADER 01378oam  2200445   450 
001 9910702957203321
005 20230902162110.0
035   $a(CKB)4950000000071916
035   $a(OCoLC)851288955
035   $a(OCoLC)994950000000071916
035   $a(EXLCZ)994950000000071916
100   $a20130629d2009      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aEmerging health care issues $efollow-on biologic drug competition
210  1$aWashington, DC :$cFederal Trade Commission,$d2009.
215   $a1 online resource (120 unnumbered pages) $ccolor illustrations
225 1 $aFederal Trade Commission report
300   $aTitle from title screen (viewed on June 25, 2013).
300   $a"June 2009."
320   $aIncludes bibliographical references.
410  0$aFederal Trade Commission report.
517   $aEmerging Health Care Issues
606   $aBiologicals
606   $aDrugs$xPrices
606   $aPrescription pricing
615  0$aBiologicals.
615  0$aDrugs$xPrices.
615  0$aPrescription pricing.
712 02$aUnited States.$bFederal Trade Commission,
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910702957203321
996   $aEmerging health care issues$93498310
997   $aUNINA